Ideas to Action:

Independent research for global prosperity

X

Global Health Policy Blog

Feed

The Bill & Melinda Gates Foundation has announced a new $104 million grant to the Global Alliance for TB Drug Development in order to:

  • Advance moxifloxacin into Phase III trials, with the goal of demonstrating its effectiveness for TB by 2010;
  • Pursue nine pre-clinical projects and identify the best of these compounds for clinical studies;
  • Work with policymakers, TB treatment providers and advocates to ensure that new TB drugs will be adopted and made accessible in developing countries;
  • Analyze drug market conditions and compliance issues to ensure the rapid adoption of a new drug regimen once it is shown to be effective.

Related Topics:

Disclaimer

CGD blog posts reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions.